effects of semaglutide on chronic kidney disease flow trial renal outcomes 2024 In the trial, researchers assessed whether the glucagon-like peptide glp-1 and chronic kidney disease

Retrieved 2009-04-05

Gowani, MD, FACP, FAAP , who is board-certified in internal medicine and pediatrics, provides clear guidance on dosage, proper injection technique, and what to expect during the early stages of treatment

Some patients report: Changes in stool consistency and frequency Increased bloating and gas A shift in gut bacteria that affects digestion Because GLP-1 medications influence bile production, the way fats are broken down and absorbed may change, sometimes leading to foul-smelling gas production

Key points for patients: GLP-1 therapies help clear skin and reduce painful, swollen joints Obesity makes PsA harder to treat, so weight loss from GLP-1 meds helps In studies, patients on GLP-1s had fewer flares, less pain, and felt better overall

Abbas A, Amin HMA

Make sure that the small meals you do eat are packed with lean protein (like chicken, fish, tofu, or Greek yoghurt) to give you sustained, long-lasting energy